Clarithromycin Prophylaxis in Preterm Infants Colonisation With Ureaplasma Urealyticum and Mycoplasma Hominis

Prophylaxis of Bronchopulmonary Dysplasia With Clarithromycin

The purpose of this study is to determine of clarithromycin effect on developing of bronchopulmonary dysplasia in preterm babies.

The investigators planned that clarithromycin treatment in preterm babies who are under 1250 grams birth weight.

The investigators aimed with this treatment, the bronchopulmonary dysplasia rate of preterm babies may decrease.

Inclusion Criteria:

• all infant must be under 1250 gram birth weight

Exclusion Criteria:

• Major congenital anomaly,
• CardiaC abnormality,
• without inform consent